Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ngm Biopharmaceuticals Inc (NGM)  
$1.54 0.00 (0.00%) as of 4:30 Thu 4/4


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 69,020,000
Market Cap: 106.29(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6003 - $4.53
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   NGM Biopharmaceuticals is a biopharmaceutical company. Co. has five product candidates in the clinic, three wholly-owned by Co. (NGM707, NGM120 and aldafermin), one being progressed by its collaborator, Merck Sharp & Dohme Corp., or Merck (MK-3655) and one optionable by Merck (NGM621). Co.'s oncology product candidates include NGM707, NGM831, NGM438 and NGM120 and their related compounds. NGM621 was engineered to bind to, and be a long-acting inhibitor of, complement C3 with the treatment goal of reducing disease progression in patients with geographic atrophy, secondary to age-related macular degeneration. MK-3655 isin Phase 2b development for the treatment of nonalcoholic steatohepatitis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 94,704 94,704 9,606,382
Total Buy Value $0 $64,854 $64,854 $87,820,003
Total People Bought 0 4 4 5
Total Buy Transactions 0 10 10 130
Total Shares Sold 0 0 0 85,082
Total Sell Value $0 $0 $0 $438,308
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 107
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Goeddel David V Director   –       •       •   2022-05-12 4 B $11.62 $966,678 I/I 83,175 37,308 2.25 14%     
   Tcg Iv Gp, Llc 10% Owner   –       –       •   2022-05-12 4 B $11.62 $966,678 I/I 83,175 37,308 1.5 14%     
   Column Group Ii Gp, Lp 10% Owner   –       –       •   2022-05-11 4 B $11.23 $935,354 I/I 83,175 34,563 1.5 25%     
   Goeddel David V Director   –       •       •   2022-05-11 4 B $11.23 $935,354 I/I 83,175 34,563 2.25 25%     
   Tcg Iv Gp, Llc 10% Owner   –       –       •   2022-05-11 4 B $11.23 $935,354 I/I 83,175 34,563 1.5 25%     
   Tcg Iv Gp, Llc 10% Owner   –       –       •   2022-05-10 4 B $11.36 $355,283 I/I 31,265 31,818 1.5 24%     
   Goeddel David V Director   –       •       •   2022-05-10 4 B $11.36 $355,283 I/I 31,265 31,818 2.25 24%     
   Column Group Ii Gp, Lp 10% Owner   –       –       •   2022-05-10 4 B $11.36 $355,283 I/I 31,265 31,818 1.5 24%     
   Tcg Iv Gp, Llc 10% Owner   –       –       •   2022-05-09 4 B $10.79 $897,699 I/I 83,175 30,786 1.5 37%     
   Goeddel David V Director   –       •       •   2022-05-09 4 B $10.79 $897,699 I/I 83,175 30,786 2.25 37%     
   Column Group Ii Gp, Lp 10% Owner   –       –       •   2022-05-09 4 B $10.79 $897,699 I/I 83,175 30,786 1.5 37%     
   Tcg Iv Gp, Llc 10% Owner   –       –       •   2022-01-25 4 B $0.00 $0 I/I 599,701 28,041 1.42 -2%     
   Column Group Ii Gp, Lp 10% Owner   –       –       •   2022-01-25 4 B $0.00 $0 I/I 599,701 28,041 1.42 -2%     
   Goeddel David V Director   –       •       •   2022-01-25 4 B $0.00 $0 I/I 599,701 28,041 2.17 -2%     
   Tcg Iv Gp, Llc 10% Owner   –       –       •   2022-01-24 4 B $0.00 $0 I/I 250,000 8,250 1.42 -8%     
   Column Group Ii Gp, Lp 10% Owner   –       –       •   2022-01-24 4 B $0.00 $0 I/I 250,000 8,250 1.42 -8%     
   Goeddel David V Director   –       •       •   2022-01-24 4 B $0.00 $0 I/I 250,000 8,250 2.17 -8%     
   Woodhouse David J Chief Executive Officer   •       •      –    2021-12-29 4 OE $7.70 $137,989 D/D 17,654 17,654     -
   Chen Jin-Long Chief Scientific Officer   •       •      –    2021-12-07 4 AS $18.60 $279,000 D/D (15,000) 908,893 -13%     
   Chen Jin-Long Chief Scientific Officer   •       •      –    2021-12-06 4 OE $1.44 $99,999 D/D 69,444 923,893     -
   Chen Jin-Long Chief Scientific Officer   •       •      –    2021-12-06 4 AS $18.21 $273,150 D/D (15,000) 854,449 -17%     
   Woodhouse David J Chief Executive Officer   •       •      –    2021-11-18 4 AS $20.02 $300,300 D/D (15,000) 0 -13%     
   Woodhouse David J Chief Executive Officer   •       •      –    2021-11-18 4 OE $7.54 $113,100 D/D 15,000 15,000     -
   Chen Jin-Long Chief Scientific Officer   •       •      –    2021-11-15 4 AS $19.56 $591,750 D/D (30,000) 869,449 -19%     
   Chen Jin-Long Chief Scientific Officer   •       •      –    2021-10-12 4 AS $20.14 $302,100 D/D (15,000) 899,449 -30%     
  107 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us